Neoadjuvant Chemo Adds Significant Treatment Benefit in Penile Cancer

In a recent study, median overall survival with neoadjuvant chemotherapy, lymphadenectomy was 37.0 months

Related Keywords

Tampa ,Florida ,United States ,Kylem Rose ,Philippe Spiess ,H Lee Moffitt Cancer Center ,Journal Of The National Cancer Institute ,Ochsner Medical Center ,Healthday News ,National Cancer ,New Orleans ,Moffitt Cancer Center ,